THE DIGITAL DIABETES PHARMACIST: A PROPOSED FRAMEWORK FOR DEDICATED CLINICAL PHARMACIST OVERSIGHT IN DIABETES DIGITAL TWIN SYSTEMS
Krishnan, Karthickeyan (2026) THE DIGITAL DIABETES PHARMACIST: A PROPOSED FRAMEWORK FOR DEDICATED CLINICAL PHARMACIST OVERSIGHT IN DIABETES DIGITAL TWIN SYSTEMS. In: INDO-KOREAN APP 202, 27.03.2026, VISTAS CHENNAI.
APP 5.pdf
Download (142kB)
Abstract
Abstract
Diabetes affects over 537 million people worldwide, and the system built to manage it is not
working. It responds to crises after they occur, treats every patient identically regardless of
their individual biology, and places over 180 clinical decisions per day on patients themselves
without adequate professional support. It was never designed for precision. It was designed
for scale.
Diabetes digital twin technology is beginning to offer something better. A digital twin is a
continuously updated, patient-specific computational model that simulates in real time how
an individual's liver, kidneys, gut, and insulin system interact, predicting where their glucose
is heading four to six hours before it gets there. The output this technology produces is deeply
pharmacological in nature. Yet no current care model assigns a clinician with
pharmacological expertise to review it continuously.
This paper proposes the Digital Diabetes Pharmacist, a dedicated clinical pharmacist whose
primary role is to review digital twin reports for a defined patient cohort daily, act on minor
drug interventions independently, co-sign major therapeutic decisions with the physician, and
escalate emergencies immediately. Every decision feeds back into the twin, making it
progressively more accurate for that specific patient over time.
The physician's engagement with the patient is episodic by nature, which is incompatible with
continuous twin oversight. The nurse manages observation and life variables, not drug
variables, and existing research has already identified where that falls short. The pharmacist
is the only clinician whose training is built around pharmacokinetics, drug interactions, and
insulin dynamics, which is precisely the output the twin generates. Implementation barriers
and a four-stage research agenda are examined in full. This framework has no precedent in
the published literature.
Keywords: Digital twin, Clinical pharmacy practice, Diabetes management
| Item Type: | Conference or Workshop Item (Paper) |
|---|---|
| Subjects: | Pharmacy Practice > Pharmacy Practice |
| Domains: | Pharmacy Practice |
| Depositing User: | Mr IR Admin |
| Last Modified: | 12 May 2026 09:24 |
| URI: | https://ir.vistas.ac.in/id/eprint/18838 |
